PERSPECTA

News from every angle

← Back to headlines

GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Approved in India and Taiwan

GC Biopharma's Hunter Syndrome treatment, 'Hunterase,' has received drug approval in both India and Taiwan, expanding its market reach.

24 Aug, 05:57 — 24 Aug, 05:57
PostShare

Sources

Showing 1 of 1 sources
morningstar22h ago

GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan - Morningstar

GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan  Morningstar

Read full article →

Related Stories

Asian Stocks Decline Amid US Tech Selloff and Iran Sanctions

30m ago

Countdown Begins for Greek Home Renovation Subsidies Up to €36,000

34m ago

Trump Buys SpaceX Shares Amid AI Concerns and Mail-in Ballot Ruling

50m ago

Tokio Marine Considers Suncorp Acquisition After Berkshire Stake

1h ago